It was silly for doctors to demand a million-child randomized-controlled trial of children under the age of 5 years in the middle of a raging Pandemic. The idea that people should be told about the COVID vaccine for children was ridiculed. There are two more silly reasons doctors give for leaving unvaccinated babies vulnerable to carbon dioxide.

I will remind you of a previous article where I described how contrarian doctors report and leave out information to minimize the effects of vaccine safety on children. Even if some studies are outliers from the general trend, it is not hard to find a study that supports a preconceived viewpoint. It is easy to ignore the fact that COVID can be bad for a small percentage of children, that rare tragedies add up to non-trivial numbers, and that the vaccine isn't perfect.

The totality of the evidence is reported by honest brokers. Doctors who don't care for sick children can misinform parents to increase the number of unvaccinated children if they cherry-pick only the studies that advance their agenda. The misleading technique is demonstrated in two recent articles.

Vaccine myocarditis: rate

Let's take a look at the latest information on vaccine-myocarditis. Men are more likely to get vaccine-myocarditis after their second vaccine dose. Moderna had a higher rate than Pfizer. Pfizer's vaccine was the only one authorized for children in the US. The rates of vaccine-myocarditis for young males after their second dose of Pfizer vaccine are listed below I'll add the other studies if I learn of them.

  • USA:  1 in 2,650, 12-17 years
  • Hong Kong: 1 in 2,700, 12-17 years
  • USA (Vaccine Safety Datalink):  1 in 6,800 12-17 years, no statistical signals for children 5-11 years
  • Meta-analysis:  1 in 7,200-20,000, 12-17 years with “low certainty” after an mRNA vaccine
  • Israel:  1 in 9,350, 16-29 years
  • Denmark: 1 in 10,000 12-17 years, either vaccine dose
  • Israel:  1 in 12,000 12-15 years
  • Ontario:  1 in 12,300, 12-17 years
  • USA (VAERS): 1 in 13,000 16-17 years, 1 in 21,500 12-15 years, 1 in 400,000 5-11 years
  • USA:  1 in 16,600, 12-17 years
  • Nordic registry data:  1 in 17,500, 16-24 years
  • Nordic Countries: 1 in 18,200, 16-24 years
  • Singapore: 1 in 20,700, 12-19 years (includes myocarditis/pericarditis and Pfizer/Moderna)
  • French national health system (Epi-phare): 1 in 38,500, 12-29 years
  • France: 1 in 52,300, 12–17 years
  • UK: 1 in 71,000 under 18 years (males and females, first or unknown dose), 1 in 100,000 (males and females, second dose)
  • Denmark:  No increased risk for males

One American vaccine safety monitoring found a rate of 1 in 400,000 for males 5-11 years old, while the other found no statistical signals. There were seven children who had recovered and four who were not. It is now known that the rate can be reduced by spacing out the vaccine doses. The study found a rate of 1 in 100,000 for adolescents with an interval between doses. Many more cases will happen in the future as almost no children older than 5 are getting their second vaccine now. I think the number of times I have talked about this topic exceeds the number of children currently hospitalized with it. A lot of doctors can say this as well.

Vaccine myocarditis: clinical course

The clinical course of vaccine-myocarditis is the same across all studies. There are markers of inflammation on tests. After a couple days, most children leave the hospital feeling better. The condition is usually mild with a good outcome.

  • “All patients in this series had a benign course; none required intensive care unit admission”. (Dionne)
  • “All 7 patients resolved their symptoms rapidly”. (Marshall )
  • “All were discharged after a median of 2 days. There were no readmissions or deaths.” (Diaz)
  • “Hospital course is mild with quick clinical recovery and excellent short-term outcomes”. (Jain)
  • “All patients received brief supportive care and were recovered or recovering at the time of this report”. (Montgomery)
  • The clinical course of vaccine-associated myocarditis-like illness appears favorable, with resolution of symptoms in all patients”. (Rosner)
  • ” All the cases were clinically mild.” (Mevorich)
  • “Acute clinical courses were generally mild.” (Gargano)
  • “The mild phenotype of myopericarditis cases in our study were comparable with cases described in other studies, except 1 patient with myocarditis and MIS-C, who needed treatment at intensive care unit.” (Nygaard)
  • “Most cases of myocarditis were mild or moderate in severity.” (Witberg)
  • “The clinical course was mild in all six patients”. (Mouch)
  • “All patients had resolution of their chest pain, were discharged from the hospital in stable condition, and were alive with preserved left ventricular ejection fraction at last contact”. (Larson)
  • “Most cases of suspected COVID-19 vaccine myocarditis occurring in persons <21>Truong)
  • “95% are considered to be mild cases.” (Israel Ministry of Health)
  • “Most vaccine-associated myocarditis events have been mild and self-limiting.” (Patone)

There are a small number of children who need treatment in the intensive care unit. They will face restrictions with vigorous activity until they do. The long-term clinical picture is mostly encouraging, even though the condition should not be minimized. A recent CDC report states.

At least 90 days after myocarditis diagnosis, most patients who were reached reported no impact on their quality of life, and most did not report missing school or work.

Radiographic abnormalities (late gadolinium enhancement) have been found on follow-up cardiac MRI several months later in several studies. While these parameters were improved from baseline, their clinical significance is unknown. As such, affected individuals will have to have their cardiac status monitored over time. Though there have been some fatalities associated with mRNA vaccines, most occurred in adults older than 50.  23.3 million American children have received two vaccine doses, and there are no clear fatalities as far as I know.

Risk versus benefits

The risk of the vaccine has to be considered in the context of the benefits. As they work with sick children, they know that their hospitals have been flooded with COVID patients, but never opened a vaccine-injury ward. That is the reason why they are alarmed. Over 300 children are being hospitalized with Covid every day because of the doctors' belief in natural immunity.

Even with Omicron, the vaccine still limits severe outcomes. The vaccine is able to prevent against MISC, which can cause more severe myocarditis in 75% of children. It seems that MISC is gone for now. The benefits of the vaccine outweigh the risks for all age and sex groups according to several studies.


What does this have to do with vaccinations for children younger than 5 years? The data from children ages 5-11 years and that younger children will receive a lower vaccine dose is reassuring to most doctors. If the COVID is given to young children, they might not have to get as many shots when they are older.

Not all doctors needed to communicate this information in a nuanced way when discussing the vaccine for young children.

The doctor warned that we had reached herd immunity over a year ago.

The small size of the studies in children under 5 makes it nearly impossible to observe rates of rare complications such as myocarditis, which occurs in 1 in 2,650 12-17 year-old boys after the 2nd dose. This complication has been associated with EKG changes in children and even concerning MRI findings months after recovering from myocarditis. The New England Journal of Medicine reported one case of vaccine-associated myocarditis death in a 22-year-old in an Israeli population study. Keep in mind that babies can’t tell you when they have myocarditis.

Last year, Dr. Tracy Hoeg suggested that pediatricians were confused by the two diseases.

The trials, in other words, enrolled only a fraction of the number of participants that would have been required to determine efficacy against end points like severe disease, hospitalization, and rare adverse events such as myocarditis, which has been linked to COVID vaccination in males in the 12- to 17-year-old age group at a rate of up to 1 in 2,700.

It has been picked.

Is it possible that Drs. Markary and Hoeg used these studies because they had the best methodology? It is absolutely true that not. They shared them because they had the highest incidence of vaccine-myocarditis. Lower rates for children ages 5-11 were shown in many large studies. The death of a 22-year-old in Israel was used to frighten parents because neither doctor reported the vaccine-myocarditis case. It was not mentioned that babies have the highest risk of dying from COVID and that over 500 children younger than 5 years have died so far. Evidence shows that the vaccine can limit the harms of the virus.

This cherry-picking matters because at least Drs. Markary and Hoeg shared an accurate number. Few people will know that they only got a small portion of the information in their essays. The governors of Florida and Virginia are probably similar to the ones they advise.

There was no need for children to bevaccinated in early 2021. Rather than say, "I was wrong", their goal is to frighten parents by showing the vaccine in the worst possible light and to make them believe the vaccine is safe. They succeeded because of the low vaccine rate for young children. They should visit a children's hospital and take a well-deserved victory lap as the number of hospitalizations for children creeps upward once again.